Top Generalizable Antivirals for Stockpiling in Emergencies: A Review and Gap Analysis
Reviews top generalizable antivirals for emergency stockpiling, analyzes their pros & cons, and points out gaps in antiviral stockpile.
February 6, 2025
by David Orchard-Webb
Professor James Rothman, Nobel Laureate, to Join the Board of Noscendo GmbH
Noscendo GmbH announced that Professor James Rothman has agreed to serve on its board as an independent director.
August 21, 2024
by Biotech Newswire
A Dark Horse in the Antibiotic World is Coming! Probably the Ultimate Weapon to Snipe Super-strong Bacteria
On April 5, 2024, a new study from a Swedish university caused a stir in the scientific community.
July 3, 2024
by Big Cat of Medical Field
Chinese mainland reports 73 new local COVID-19 cases
The Chinese mainland on Tuesday recorded 73 locally transmitted COVID-19 cases.
February 9, 2022
by NMPA
Top Bulk Griseofulvin Powder Manufacturers in China Recommended
Description, Specifications and Forms, Manufacturing Process, etc., of Griseofulvin.
April 23, 2021
by PharmaSources.com
Evolving World of Pharma: AMR-pushing healthcare back in time
Most of us take for granted the ability to fight infections that, less than a century ago, could have caused severe illness, disfigurement or death.
December 13, 2019
by Sarah Harding
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections.
July 22, 2019
by drugs
Merck’s Recarbrio gets FDA approval for treatment of infections
The US Food and Drug Administration (FDA) has approved Merck’s Recarbrio injection for the treatment of complicated urinary tract infections (cUTI) and intra-abdominal infections (cIAI).
July 19, 2019
by pharmaceutical-technology
FDA Approves Treatment for Complicated Urinary Tract, Complicated Intra-Abdominal Infections
The U.S. Food and Drug Administration (FDA) has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
July 19, 2019
by americanpharmaceuticalreview
Gilead to donate 2.4M bottles of Truvada in push to limit HIV infections
With HIV rates in the U.S. holding steady, health officials are looking to drugmakers for help containing its spread.
May 13, 2019
by fiercepharma
Personalizing viral phages to fight resistant infections
The Howard Hughes Medical Institute and the University of Pittsburgh started a program called SEA-PHAGES in the 1990s that offered college students an opportunity to hunt for bacteria-killing viruses known as bacteriophages.
May 10, 2019
by fiercebiotech
Absorbable antibiotic envelope cuts cardiac infections
An absorbable antibiotic envelope could cut the number of cardiac infections after surgery to implant or replace cardioverter defibrillators and pacemakers…
March 19, 2019
by europeanpharmaceuticalreview